Latest Novo Nordisk Stories
PRINCETON, N.J. and INDIANAPOLIS, Ind., Nov. 15, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and Chip Ganassi Racing Teams, Inc. announced today that the two organizations have entered into a multi-year extension of their partnership. Novo Nordisk will remain the primary sponsor of the No. 83 Novo Nordisk Chip Ganassi Racing entry, driven by Charlie Kimball in the IZOD IndyCar Series. To view the multimedia assets associated with this release, please click:...
PRINCETON, N.J., Nov. 2, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that it has donated $50,000 to the Diabetes Hands Foundation (DHF), a non-profit organization that raises diabetes awareness and connects people touched by the condition. The donation recognizes the success of the Drive the Switch program, which has motivated more than 10,000 people to pledge to talk to loved ones and their doctor about options for insulin delivery, like the...
PRINCETON, N.J., Oct. 28, 2011 /PRNewswire/ -- Novo Nordisk was ranked 22nd on the first-ever ranking of the top 25 multinational workplaces, adding to other honors it has received as a competitive employer in New Jersey, the United States, and around the world. This recognition was sponsored by the Great Place to Work® Institute, Inc., known for its efforts to identify and share best practices in company management and culture. (Logo:...
BOSTON, Oct. 5, 2011 /PRNewswire/ -- Leading diabetes healthcare company Novo Nordisk announced today that it has awarded $150,000 in sponsorships to seven Greater Boston community organizations to support programs that educate people living with type 2 diabetes to help them reduce their risks for long term complications. The Boston sponsorships are part of the nationwide Novo Nordisk Community Care program - a new and innovative initiative that aims to promote enduring, sustainable change...
RESTON, Va., Oct. 4, 2011 /PRNewswire/ -- The Entertainment Industries Council, Inc. (EIC), a non-profit organization that deals with important health and social issues, and Novo Nordisk, a world leader in diabetes care, have partnered with Stephen Wallem on a diabetes campaign entitled Picture This: Diabetes to increase awareness and to encourage better management of the disease. A new TV PSA featuring the actor is a central focus of the campaign and is currently being distributed to...
Medicare Diabetes Screening Project, Metro Atlanta YMCA and Atlanta Regional Commission team up to provide older adults with a game plan to prevent diabetes Proven program could save Medicare $7 billion or more, according to recent research ATLANTA, Sept. 28, 2011 /PRNewswire-USNewswire/ -- The Medicare Diabetes Screening Project (MDSP) in collaboration with the Atlanta Regional Commission's Area Agency on Aging (AAA) and the Metro Atlanta YMCA today launched a first in the nation diabetes...
ATLANTA, Sept. 15, 2011 /PRNewswire/ -- This evening, Novo Nordisk awarded sponsorships totaling $80,000 to 4 metro Atlanta community organizations to support programs that educate people living with type 2 diabetes on how to better manage their diabetes and reduce the risk of long-term diabetes related complications. The sponsorships are part of the Novo Nordisk Community Care program - a new initiative that aims to promote enduring, sustainable change for people living with diabetes. The...
PRINCETON, N.J., Sept. 14, 2011 /PRNewswire/ -- Today, Novo Nordisk, a world leader in diabetes care, launched a free 5-volume diabetes educational e-book series, designed to help patients work with their health care team to better manage their diabetes. The e-book series is part of Cornerstones4Care(TM), an innovative patient support program that provides highly customizable diabetes information through the comprehensive interactive website www.Cornerstones4Care.com. To view the...
BRIDGEWATER, N.J., Sept. 12, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million. This financing will support the commercialization of the V-Go(TM) Disposable Insulin Delivery Device, which provides basal-bolus insulin therapy for adult patients with diabetes who require insulin. Welsh, Carson,...
PRINCETON, N.J., Sept. 7, 2011 /PRNewswire/ -- Novo Nordisk Inc. announced today that Dr. Eddie Li, has been appointed to join the diabetes leader as Vice President, Regulatory Affairs starting September 12. Reporting to Anne Philips, M.D., Corporate Vice President, Clinical Development, Medical and Regulatory Affairs for North America, Dr. Li brings over 20 years of industry, public sector, and academic experience in the field of regulatory affairs and safety. He'll be leading Novo...
